CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pyrimidine ribonucleosides
Accession: CHEBI:39446
browse the term
Synonyms: alt_id: CHEBI:13784; CHEBI:26445; CHEBI:7263
G
Cda
cytidine deaminase
increases metabolic processing
ISO
CDA protein results in increased metabolism of 5-fluorocytidine
CTD
PMID:21804305
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
G
Abcc5
ATP binding cassette subfamily C member 5
increases export
ISO
ABCC5 protein results in increased export of 5-fluorouridine
CTD
PMID:15897250
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Sod1
superoxide dismutase 1
affects binding
ISO
5-fluorouridine binds to SOD1 protein; 5-fluorouridine binds to SOD1 protein mutant form
CTD
PMID:23612299
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Abcb7
ATP binding cassette subfamily B member 7
decreases response to substance
ISO
ABCB7 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
G
Acaa1a
acetyl-CoA acyltransferase 1A
increases response to substance
ISO
ACAA1 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
G
Agpat2
1-acylglycerol-3-phosphate O-acyltransferase 2
increases response to substance
ISO
AGPAT2 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
increases response to substance
ISO
AGR2 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Akr1b1
aldo-keto reductase family 1 member B1
decreases response to substance
ISO
AKR1B1 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1c3
aldo-keto reductase family 1, member C3
increases response to substance
ISO
AKR1C3 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
capecitabine decreases expression and phosphorylation of AKT1 protein in colon
RGD
PMID:30789971
RGD:151893289
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Aqp8
aquaporin 8
increases expression
ISO
Capecitabine results in increased expression of AQP8 mRNA
CTD
PMID:36183961
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
G
Arl4d
ADP-ribosylation factor like GTPase 4D
decreases response to substance
ISO
ARL4D protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
increases expression
ISO
Capecitabine results in increased expression of ATP12A mRNA
CTD
PMID:36183961
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
G
Axl
Axl receptor tyrosine kinase
decreases response to substance
ISO
AXL protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
C3
complement C3
decreases expression
ISO
Capecitabine results in decreased expression of C3 mRNA
CTD
PMID:36183961
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Canx
calnexin
multiple interactions
ISO
CANX results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]
CTD
PMID:18678097
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Cat
catalase
decreases activity
EXP
Capecitabine results in decreased activity of CAT protein
CTD
PMID:29117755
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl19
C-C motif chemokine ligand 19
decreases expression
ISO
Capecitabine results in decreased expression of CCL19 mRNA
CTD
PMID:36183961
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl21
C-C motif chemokine ligand 21
decreases expression
ISO
Capecitabine results in decreased expression of CCL21 mRNA
CTD
PMID:36183961
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
G
Ccn1
cellular communication network factor 1
decreases response to substance decreases expression
ISO
CCN1 protein results in decreased susceptibility to Capecitabine Capecitabine results in decreased expression of CCN1 mRNA
CTD
PMID:16734730 PMID:36183961
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
decreases expression
ISO
Capecitabine results in decreased expression of CDKN2A protein
CTD
PMID:17904787
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
CES1 protein results in increased hydrolysis of and results in increased activity of Capecitabine
CTD
PMID:15687373
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Ces2h
carboxylesterase 2H
multiple interactions increases response to substance
ISO
CES2 protein results in increased hydrolysis of and results in increased activity of Capecitabine CES2 gene polymorphism results in increased susceptibility to Capecitabine
CTD
PMID:15687373 PMID:18473752
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cib1
calcium and integrin binding 1
increases response to substance
ISO
CIB1 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
G
Cldn3
claudin 3
increases response to substance
ISO
CLDN3 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
ISO
Capecitabine decreases expression of CXCL12 protein in liver and colon
RGD
PMID:30789971
RGD:151893289
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
Capecitabine results in increased expression of CXCL1
CTD
PMID:35147423
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases expression
ISO
Capecitabine decreases expression of CXCR4 protein in liver and colon
RGD
PMID:30789971
RGD:151893289
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Dpyd
dihydropyrimidine dehydrogenase
increases expression decreases response to substance affects response to substance
ISO
Capecitabine results in increased expression of DPYD mRNA DPYD protein results in decreased susceptibility to Capecitabine DPYD protein affects the susceptibility to Capecitabine
CTD
PMID:16734730 PMID:17611699 PMID:18846242
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dse
dermatan sulfate epimerase
decreases response to substance
ISO
DSE protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr20:26,118,194...26,196,889
Ensembl chr20:26,118,196...26,196,992
G
Eps8
EGFR pathway substrate 8, signaling adaptor
increases response to substance
ISO
EPS8 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
G
Erbb3
erb-b2 receptor tyrosine kinase 3
increases response to substance
ISO
ERBB3 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
G
Fcrla
Fc receptor-like A
decreases expression
ISO
Capecitabine results in decreased expression of FCRLA mRNA
CTD
PMID:36183961
NCBI chr13:83,160,453...83,170,170
Ensembl chr13:83,160,398...83,170,762
G
Fhl1
four and a half LIM domains 1
decreases response to substance
ISO
FHL1 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
G
Flii
FLII, actin remodeling protein
decreases response to substance
ISO
FLII protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970
G
Fuca1
alpha-L-fucosidase 1
increases response to substance
ISO
FUCA1 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 5:148,152,718...148,169,972
Ensembl chr 5:148,152,700...148,169,972
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
increases expression
ISO
Capecitabine results in increased expression of GATD3A mRNA
CTD
PMID:36183961
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gpx1
glutathione peroxidase 1
decreases activity
EXP
Capecitabine results in decreased activity of GPX1 protein
CTD
PMID:29117755
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
ISO
Capecitabine results in decreased expression of HBA1 mRNA
CTD
PMID:36183961
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
G
Hba-a3
hemoglobin alpha, adult chain 3
decreases expression
ISO
Capecitabine results in decreased expression of HBA2 mRNA
CTD
PMID:36183961
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
G
Hbb
hemoglobin subunit beta
decreases expression
ISO
Capecitabine results in decreased expression of HBB mRNA
CTD
PMID:36183961
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hdgfl3
HDGF like 3
decreases response to substance
ISO
HDGFL3 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719
G
Hif1a
hypoxia inducible factor 1 subunit alpha
decreases response to substance ameliorates
ISO
HIF1A protein results in decreased susceptibility to Capecitabine capecitabine decreases expression of HIF1A protein in colon
CTD RGD
PMID:16734730 PMID:30789971
RGD:151893289
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hras
HRas proto-oncogene, GTPase
decreases response to substance
ISO
HRAS protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Il17rb
interleukin 17 receptor B
increases response to substance
ISO
IL17RB protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr16:5,180,431...5,194,125
Ensembl chr16:5,180,432...5,194,125
G
Il1r2
interleukin 1 receptor type 2
increases response to substance
ISO
IL1R2 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il6
interleukin 6
increases expression multiple interactions
ISO
Capecitabine metabolite results in increased expression of IL6 mRNA; Capecitabine results in increased expression of IL6 alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Capecitabine metabolite results in increased expression of IL6 mRNA]
CTD
PMID:35147423
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
JUNB results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]
CTD
PMID:18678097
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Lgals4
galectin 4
increases response to substance
ISO
LGALS4 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:84,124,766...84,132,481
Ensembl chr 1:84,124,764...84,132,481
G
Lrrc15
leucine rich repeat containing 15
decreases expression
ISO
Capecitabine results in decreased expression of LRRC15 mRNA
CTD
PMID:36183961
NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267
G
Mdm4
MDM4 regulator of p53
multiple interactions
ISO
MDM4 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]
CTD
PMID:18678097
NCBI chr13:44,432,596...44,516,165
Ensembl chr13:44,406,213...44,474,226
G
Mmp2
matrix metallopeptidase 2
multiple interactions decreases expression
ISO
MMP2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] capecitabine decreases expression of MMP2 protein in colon
CTD RGD
PMID:18678097 PMID:30789971
RGD:151893289
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mre11
MRE11 homolog, double strand break repair nuclease
decreases response to substance
ISO
MRE11 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
G
Ms4a1
membrane spanning 4-domains A1
decreases expression
ISO
Capecitabine results in decreased expression of MS4A1 mRNA
CTD
PMID:36183961
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
G
Myb
MYB proto-oncogene, transcription factor
increases response to substance
ISO
MYB protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Myrf
myelin regulatory factor
increases response to substance
ISO
MYRF protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
decreases expression
ISO
Capecitabine results in decreased expression of NR4A1 mRNA
CTD
PMID:36183961
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
decreases expression
ISO
Capecitabine results in decreased expression of NR4A2 mRNA
CTD
PMID:36183961
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Pax5
paired box 5
decreases expression
ISO
Capecitabine results in decreased expression of PAX5 mRNA
CTD
PMID:36183961
NCBI chr 5:58,763,334...58,945,719
Ensembl chr 5:58,765,036...58,944,326
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
multiple interactions
ISO
capecitabine decreases expression and phosphorylation of PIK3CB protein in colon
RGD
PMID:30789971
RGD:151893289
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
G
Pkd2
polycystin 2, transient receptor potential cation channel
decreases response to substance
ISO
PKD2 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Pkp2
plakophilin 2
increases response to substance
ISO
PKP2 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr11:84,661,783...84,727,730
Ensembl chr11:84,661,783...84,727,730
G
Plce1
phospholipase C, epsilon 1
increases response to substance
ISO
PLCE1 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
G
Ppa1
inorganic pyrophosphatase 1
increases response to substance
ISO
PPA1 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
decreases response to substance
ISO
PRKACB protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Capecitabine results in decreased expression of PTGS2 protein Capecitabine metabolite results in decreased expression of PTGS2
CTD
PMID:17904787 PMID:35147423
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
decreases response to substance
ISO
PTPN13 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Pygb
glycogen phosphorylase B
increases response to substance
ISO
PYGB protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
G
Rab40b
Rab40b, member RAS oncogene family
increases response to substance
ISO
RAB40B protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr10:106,631,514...106,659,090
Ensembl chr10:106,631,514...106,659,090
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
RB1 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]
CTD
PMID:18678097
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
multiple interactions
ISO
RBBP4 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]
CTD
PMID:18678097
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rpa1
replication protein A1
decreases response to substance
ISO
RPA1 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rras2
RAS related 2
decreases response to substance
ISO
RRAS2 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
RT1-Ba
RT1 class II, locus Ba
decreases expression
ISO
Capecitabine results in decreased expression of HLA-DQA1 mRNA
CTD
PMID:36183961
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
Sik1
salt-inducible kinase 1
decreases expression
ISO
Capecitabine results in decreased expression of SIK1 mRNA
CTD
PMID:36183961
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Slc26a3
solute carrier family 26 member 3
increases expression
ISO
Capecitabine results in increased expression of SLC26A3 mRNA
CTD
PMID:36183961
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
multiple interactions
ISO
Capecitabine inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]
CTD
PMID:30863990
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Sod1
superoxide dismutase 1
decreases activity
EXP
Capecitabine results in decreased activity of SOD1 protein
CTD
PMID:29117755
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Stip1
stress-induced phosphoprotein 1
decreases response to substance
ISO
STIP1 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Tcf7l2
transcription factor 7 like 2
multiple interactions
ISO
TCF7L2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]
CTD
PMID:18678097
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
G
Tead1
TEA domain transcription factor 1
decreases response to substance
ISO
TEAD1 protein results in decreased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 1:166,791,900...167,010,591
Ensembl chr 1:166,792,628...167,003,369
G
Tff1
trefoil factor 1
increases response to substance
ISO
TFF1 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Trim15
tripartite motif containing 15
increases response to substance
ISO
TRIM15 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr20:1,700,905...1,710,249
Ensembl chr20:1,700,905...1,710,249
G
Trim31
tripartite motif-containing 31
increases expression
ISO
Capecitabine results in increased expression of TRIM31 mRNA
CTD
PMID:36183961
NCBI chr20:1,653,165...1,666,494
Ensembl chr20:1,653,165...1,666,494
G
Tyms
thymidylate synthetase
affects expression decreases response to substance multiple interactions
ISO
Capecitabine affects the expression of TYMS mRNA TYMS protein results in decreased susceptibility to Capecitabine [TYMS enhancer polymorphism co-treated with VEGFA gene SNP] affects the susceptibility to [Capecitabine co-treated with oxaliplatin]
CTD
PMID:16438929 PMID:16734730 PMID:21048041
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Upk3a
uroplakin 3A
increases expression
ISO
Capecitabine results in increased expression of UPK3A mRNA
CTD
PMID:36183961
NCBI chr 7:116,128,981...116,139,950
Ensembl chr 7:116,134,874...116,139,948
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression
ISO
[TYMS enhancer polymorphism co-treated with VEGFA gene SNP] affects the susceptibility to [Capecitabine co-treated with oxaliplatin] capecitabine decreases expression of VEGFA protein in blood serum and colon
CTD RGD
PMID:21048041 PMID:30789971
RGD:151893289
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Zfp706
zinc finger protein 706
increases response to substance
ISO
ZNF706 protein results in increased susceptibility to Capecitabine
CTD
PMID:16734730
NCBI chr 7:68,167,496...68,174,121
Ensembl chr 7:68,166,323...68,174,148
G
Adora1
adenosine A1 receptor
increases activity
EXP
Cytidine results in increased activity of ADORA1 protein
CTD
PMID:18313046
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2a
adenosine A2a receptor
increases activity
EXP
Cytidine results in increased activity of ADORA2A protein
CTD
PMID:18313046
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
[Chlorine binds to Cytidine] which results in decreased expression of CCL5 mRNA
CTD
PMID:31066272
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Gypa
glycophorin A
multiple interactions
ISO
Cytidine inhibits the reaction [teriflunomide results in increased expression of GYPA protein]
CTD
PMID:12181422
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
increases abundance multiple interactions
ISO
IDH2 protein mutant form results in increased abundance of Cytidine Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Cytidine]
CTD
PMID:27469509
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Chlorine binds to Cytidine] which results in increased expression of IL1B mRNA; [Chlorine binds to Cytidine] which results in increased expression of IL1B protein
CTD
PMID:31066272
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Slc28a1
solute carrier family 28 member 1
multiple interactions increases transport
ISO
Cytidine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine] SLC28A1 protein results in increased transport of Cytidine
CTD
PMID:9124315 PMID:10772724
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
G
Slc29a1
solute carrier family 29 member 1
multiple interactions
ISO EXP
Cytidine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]
CTD
PMID:9353301 PMID:11085929
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc29a2
solute carrier family 29 member 2
multiple interactions
ISO
Cytidine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]
CTD
PMID:11085929
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Upp1
uridine phosphorylase 1
increases metabolic processing
ISO
UPP1 protein results in increased metabolism of Cytidine
CTD
PMID:15772079
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Aars1
alanyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of AARS mRNA
CTD
PMID:37748715
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
G
Abcf3
ATP binding cassette subfamily F member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ABCF3 mRNA
CTD
PMID:37748715
NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211
G
Ace
angiotensin I converting enzyme
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ACE mRNA
CTD
PMID:37748715
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adap2
ArfGAP with dual PH domains 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADAP2 mRNA
CTD
PMID:37748715
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Adgra2
adhesion G protein-coupled receptor A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA2 mRNA
CTD
PMID:37748715
NCBI chr16:64,932,964...64,971,433
Ensembl chr16:64,933,315...64,971,483
G
Adgra3
adhesion G protein-coupled receptor A3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA3 mRNA
CTD
PMID:37748715
NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332
G
Adgrg1
adhesion G protein-coupled receptor G1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRG1 mRNA
CTD
PMID:37748715
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
G
Akirin1
akirin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AKIRIN1 mRNA
CTD
PMID:37748715
NCBI chr 5:135,989,378...136,004,782
Ensembl chr 5:135,989,465...136,004,762
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ALDH18A1 mRNA
CTD
PMID:37748715
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Alkbh5
alkB homolog 5, RNA demethylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ALKBH5 mRNA
CTD
PMID:37748715
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APBB1IP mRNA
CTD
PMID:37748715
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apela
apelin receptor early endogenous ligand
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APELA mRNA
CTD
PMID:37748715
NCBI chr16:24,694,356...24,703,466
Ensembl chr16:24,694,324...24,703,465
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARIH2 mRNA
CTD
PMID:37748715
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
G
Arl14ep
ADP-ribosylation factor like GTPase 14 effector protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARL14EP mRNA
CTD
PMID:37748715
NCBI chr 3:93,441,952...93,454,282
Ensembl chr 3:93,443,183...93,454,155
G
Arnt
aryl hydrocarbon receptor nuclear translocator
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARNT mRNA
CTD
PMID:37748715
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arrdc4
arrestin domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARRDC4 mRNA
CTD
PMID:37748715
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Asb8
ankyrin repeat and SOCS box-containing 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ASB8 mRNA
CTD
PMID:37748715
NCBI chr 7:129,261,397...129,297,492
Ensembl chr 7:129,261,397...129,297,485
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of ASNS mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of ASNS mRNA]
CTD
PMID:37748715
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Ate1
arginyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATE1 mRNA
CTD
PMID:37748715
NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908
G
Atf2
activating transcription factor 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF2 mRNA
CTD
PMID:37748715
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atf3
activating transcription factor 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ATF3 mRNA
CTD
PMID:37748715
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF4 mRNA
CTD
PMID:37748715
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF5 mRNA
CTD
PMID:37748715
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF6 mRNA
CTD
PMID:37748715
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Aup1
AUP1, lipid droplet regulating VLDL assembly factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AUP1 mRNA
CTD
PMID:37748715
NCBI chr 4:115,560,274...115,563,346
Ensembl chr 4:115,560,261...115,563,346
G
Avil
advillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AVIL mRNA
CTD
PMID:37748715
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of B3GALNT1 mRNA
CTD
PMID:37748715
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
G
Bbx
BBX high mobility group box domain containing
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BBX mRNA
CTD
PMID:37748715
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BGLAP mRNA
CTD
PMID:37748715
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Brms1l
BRMS1 like transcriptional repressor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BRMS1L mRNA
CTD
PMID:37748715
NCBI chr 6:73,266,673...73,300,630
Ensembl chr 6:73,266,691...73,300,631
G
Calml4
calmodulin-like 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CALML4 mRNA
CTD
PMID:37748715
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CARHSP1 mRNA
CTD
PMID:37748715
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Carmil1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LRRC16A mRNA
CTD
PMID:37748715
NCBI chr17:40,807,921...41,088,326
Ensembl chr17:40,808,389...41,088,326
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of CARS mRNA
CTD
PMID:37748715
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Cbx7
chromobox 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CBX7 mRNA
CTD
PMID:37748715
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Ccnb2
cyclin B2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CCNB2 mRNA
CTD
PMID:37748715
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Cd68
Cd68 molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CD68 mRNA
CTD
PMID:37748715
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CDCA3 mRNA
CTD
PMID:37748715
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEBPG mRNA
CTD
PMID:37748715
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
G
Cep170
centrosomal protein 170
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEP170 mRNA
CTD
PMID:37748715
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of CHAC1 mRNA]
CTD
PMID:37748715
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Coa7
cytochrome c oxidase assembly factor 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COA7 mRNA
CTD
PMID:37748715
NCBI chr 5:123,069,356...123,080,942
Ensembl chr 5:123,069,371...123,080,199
G
Commd5
COMM domain containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COMMD5 mRNA
CTD
PMID:37748715
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COX6A2 mRNA
CTD
PMID:37748715
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CPT1A mRNA
CTD
PMID:37748715
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CRYZL1 mRNA
CTD
PMID:37748715
NCBI chr11:30,933,140...30,977,936
Ensembl chr11:30,933,144...30,977,867
G
Csf3r
colony stimulating factor 3 receptor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CSF3R mRNA
CTD
PMID:37748715
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Ctps2
CTP synthase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CTPS2 mRNA
CTD
PMID:37748715
NCBI chr X:31,645,873...31,786,733
Ensembl chr X:31,645,873...31,786,733
G
Cyb5b
cytochrome b5 type B
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Dcaf15
DDB1 and CUL4 associated factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DCAF15 mRNA
CTD
PMID:37748715
NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277
G
Ddhd2
DDHD domain containing 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDHD2 mRNA
CTD
PMID:37748715
NCBI chr16:66,319,469...66,349,025
Ensembl chr16:66,319,466...66,349,023
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of DDIT3 mRNA]
CTD
PMID:37748715
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of DDIT4 mRNA
CTD
PMID:37748715
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddx19b
DEAD-box helicase 19B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX19B mRNA
CTD
PMID:37748715
NCBI chr19:38,968,215...38,998,907
Ensembl chr19:38,968,215...38,997,259
G
Ddx4
DEAD-box helicase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX4 mRNA
CTD
PMID:37748715
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
G
Def8
differentially expressed in FDCP 8 homolog
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DEF8 mRNA
CTD
PMID:37748715
NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638
G
Dnajc5g
DnaJ heat shock protein family (Hsp40) member C5 gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNAJC5G mRNA
CTD
PMID:37748715
NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNMT1 mRNA
CTD
PMID:37748715
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dusp11
dual specificity phosphatase 11
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP11 mRNA
CTD
PMID:37748715
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
G
Dusp16
dual specificity phosphatase 16
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP16 mRNA
CTD
PMID:37748715
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp19
dual specificity phosphatase 19
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP19 mRNA
CTD
PMID:37748715
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYNLL1 mRNA
CTD
PMID:37748715
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Dyrk4
dual specificity tyrosine phosphorylation regulated kinase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYRK4 mRNA
CTD
PMID:37748715
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
G
E2f8
E2F transcription factor 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of E2F8 mRNA
CTD
PMID:37748715
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:37748715
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ELF1 mRNA
CTD
PMID:37748715
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
G
Emc9
ER membrane protein complex subunit 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EMC9 mRNA
CTD
PMID:37748715
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
G
Enpep
glutamyl aminopeptidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ENPEP mRNA
CTD
PMID:37748715
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EPB41L5 mRNA
CTD
PMID:37748715
NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360
G
Exosc6
exosome component 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of EXOSC6 mRNA
CTD
PMID:37748715
NCBI chr19:39,022,171...39,023,585
Ensembl chr19:39,022,183...39,023,515
G
Fam98a
family with sequence similarity 98, member A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FAM98A mRNA
CTD
PMID:37748715
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
G
Fanca
FA complementation group A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FANCA mRNA
CTD
PMID:37748715
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
G
Fbxl12
F-box and leucine-rich repeat protein 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXL12 mRNA
CTD
PMID:37748715
NCBI chr 8:19,175,864...19,183,373
Ensembl chr 8:19,160,352...19,183,607
G
Fbxo5
F-box protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXO5 mRNA
CTD
PMID:37748715
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fetub
fetuin B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FETUB mRNA
CTD
PMID:37748715
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
G
Fhip2b
FHF complex subunit HOOK interacting protein 2B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FAM160B2 mRNA
CTD
PMID:37748715
NCBI chr15:45,656,641...45,674,603
Ensembl chr15:45,656,647...45,674,105
G
Foxk2
forkhead box K2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FOXK2 mRNA
CTD
PMID:37748715
NCBI chr10:106,542,643...106,592,569
Ensembl chr10:106,542,566...106,592,563
G
Fzd4
frizzled class receptor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FZD4 mRNA
CTD
PMID:37748715
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GADD45A mRNA
CTD
PMID:37748715
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GARS mRNA
CTD
PMID:37748715
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GAS2 mRNA
CTD
PMID:37748715
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gdf15
growth differentiation factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GDF15 mRNA
CTD
PMID:37748715
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gid4
GID complex subunit 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GID4 mRNA
CTD
PMID:37748715
NCBI chr10:45,221,556...45,247,627
Ensembl chr10:45,245,754...45,247,621 Ensembl chr10:45,245,754...45,247,621
G
Glb1
galactosidase, beta 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GLB1 mRNA
CTD
PMID:37748715
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GPT2 mRNA
CTD
PMID:37748715
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of GRB10 mRNA
CTD
PMID:37748715
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
G
Grcc10
gene rich cluster, C10 gene
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GRCC10 mRNA
CTD
PMID:37748715
NCBI chr 4:157,551,276...157,552,924
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHA mRNA
CTD
PMID:37748715
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHB mRNA
CTD
PMID:37748715
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hax1
HCLS1 associated protein X-1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HAX1 mRNA
CTD
PMID:37748715
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
G
Helz
helicase with zinc finger
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HELZ mRNA
CTD
PMID:37748715
NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA]
CTD
PMID:37748715
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Herpud2
HERPUD family member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HERPUD2 mRNA
CTD
PMID:37748715
NCBI chr 8:23,573,374...23,618,380
Ensembl chr 8:23,573,379...23,617,874
G
Hexa
hexosaminidase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXA mRNA
CTD
PMID:37748715
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXIM1 mRNA
CTD
PMID:37748715
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
G
Hmox1
heme oxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HMOX1 mRNA
CTD
PMID:37748715
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IARS mRNA
CTD
PMID:37748715
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ID2 mRNA
CTD
PMID:37748715
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Inip
INTS3 and NABP interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of INIP mRNA
CTD
PMID:37748715
NCBI chr 5:74,648,392...74,662,628
Ensembl chr 5:74,648,392...74,662,628
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:37748715
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRF2BP2 mRNA
CTD
PMID:37748715
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Jam3
junctional adhesion molecule 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JAM3 mRNA
CTD
PMID:37748715
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JDP2 mRNA
CTD
PMID:37748715
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Lgals1
galectin 1
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of LGALS1 mRNA]
CTD
PMID:37748715
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lig1
DNA ligase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LIG1 mRNA
CTD
PMID:37748715
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LRFN1 mRNA
CTD
PMID:37748715
NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449
G
Lyrm7
LYR motif containing 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LYRM7 mRNA
CTD
PMID:37748715
NCBI chr10:38,964,299...38,983,628
Ensembl chr10:38,964,311...38,983,601
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAP2K5 mRNA
CTD
PMID:37748715
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAPRE3 mRNA
CTD
PMID:37748715
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MCAM mRNA
CTD
PMID:37748715
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mdh1
malate dehydrogenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MDH1 mRNA
CTD
PMID:37748715
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Midn
midnolin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MIDN mRNA
CTD
PMID:37748715
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MKNK1 mRNA
CTD
PMID:37748715
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
G
Mob4
MOB family member 4, phocein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MOB4 mRNA
CTD
PMID:37748715
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
G
Mrps12
mitochondrial ribosomal protein S12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS12 mRNA
CTD
PMID:37748715
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
G
Mrps27
mitochondrial ribosomal protein S27
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS27 mRNA
CTD
PMID:37748715
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MSMO1 mRNA
CTD
PMID:37748715
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Mt2A
metallothionein 2A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MT2 mRNA
CTD
PMID:37748715
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtarc2
mitochondrial amidoxime reducing component 2
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:96,362,810...96,397,284
G
Mtbp
MDM2 binding protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTBP mRNA
CTD
PMID:37748715
NCBI chr 7:86,973,215...87,055,775
Ensembl chr 7:86,973,069...87,050,827
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTHFD1L mRNA
CTD
PMID:37748715
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of MTHFD2 mRNA]
CTD
PMID:37748715
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mtx1
Metaxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTX1 mRNA
CTD
PMID:37748715
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MYC mRNA
CTD
PMID:37748715
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nabp1
nucleic acid binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NABP1 mRNA
CTD
PMID:37748715
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NARS mRNA
CTD
PMID:37748715
NCBI chr18:57,989,308...58,005,584
Ensembl chr18:57,989,308...58,005,622
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPD2 mRNA
CTD
PMID:37748715
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPG mRNA
CTD
PMID:37748715
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCOR1 mRNA
CTD
PMID:37748715
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
G
Nectin1
nectin cell adhesion molecule 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PVRL1 mRNA
CTD
PMID:37748715
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSF mRNA
CTD
PMID:37748715
NCBI chr10:88,727,912...88,857,375
Ensembl chr10:88,727,912...88,857,386
G
Nsun3
NOP2/Sun RNA methyltransferase 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSUN3 mRNA
CTD
PMID:37748715
NCBI chr11:37,490,832...37,575,607
Ensembl chr11:37,490,838...37,568,543
G
Ntaq1
N-terminal glutamine amidase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of WDYHV1 mRNA
CTD
PMID:37748715
NCBI chr 7:89,684,318...89,704,484
Ensembl chr 7:89,684,323...89,704,474
G
Nup85
nucleoporin 85
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NUP85 mRNA
CTD
PMID:37748715
NCBI chr10:100,806,482...100,825,029
Ensembl chr10:100,806,437...100,825,043
G
Nupr1
nuclear protein 1, transcriptional regulator
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of NUPR1 mRNA]
CTD
PMID:37748715
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Nxf7
nuclear RNA export factor 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of NXF2 mRNA
CTD
PMID:37748715
NCBI chr X:98,535,374...98,552,562
Ensembl chr X:98,535,375...98,552,526
G
Ogdh
oxoglutarate dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OGDH mRNA
CTD
PMID:37748715
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Oip5
Opa interacting protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OIP5 mRNA
CTD
PMID:37748715
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Optn
optineurin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OPTN mRNA
CTD
PMID:37748715
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OSGEPL1 mRNA
CTD
PMID:37748715
NCBI chr 9:48,214,995...48,229,440
Ensembl chr 9:48,215,402...48,229,388
G
P2rx3
purinergic receptor P2X 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P2RX3 mRNA
CTD
PMID:37748715
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
P2rx7
purinergic receptor P2X 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of P2RX7 mRNA
CTD
PMID:37748715
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
P4ha2
prolyl 4-hydroxylase subunit alpha 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P4HA2 mRNA
CTD
PMID:37748715
NCBI chr10:38,243,136...38,271,983
Ensembl chr10:38,243,139...38,287,314
G
Pak2
p21 (RAC1) activated kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PAK2 mRNA
CTD
PMID:37748715
NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816
G
Pde3a
phosphodiesterase 3A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE3A mRNA
CTD
PMID:37748715
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pde4dip
phosphodiesterase 4D interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE4DIP mRNA
CTD
PMID:37748715
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pds5b
PDS5 cohesin associated factor B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDS5B mRNA
CTD
PMID:37748715
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Pex1
peroxisomal biogenesis factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PEX1 mRNA
CTD
PMID:37748715
NCBI chr 4:30,519,950...30,558,953
Ensembl chr 4:30,519,955...30,558,921
G
Pgam2
phosphoglycerate mutase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGAM2 mRNA
CTD
PMID:37748715
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
G
Pgp
phosphoglycolate phosphatase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGP mRNA
CTD
PMID:37748715
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Pmch
pro-melanin-concentrating hormone
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PMCH mRNA
CTD
PMID:37748715
NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250
G
Polr2a
RNA polymerase II subunit A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of POLR2A mRNA
CTD
PMID:37748715
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R15A mRNA
CTD
PMID:37748715
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R3C mRNA
CTD
PMID:37748715
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PSAT1 mRNA
CTD
PMID:37748715
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psph
phosphoserine phosphatase
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of PSPH mRNA
CTD
PMID:37748715
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PTK2 mRNA
CTD
PMID:37748715
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Rab21
RAB21, member RAS oncogene family
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAB21 mRNA
CTD
PMID:37748715
NCBI chr 7:50,904,050...50,928,890
Ensembl chr 7:50,904,057...50,928,839
G
Rabggta
Rab geranylgeranyltransferase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RABGGTA mRNA
CTD
PMID:37748715
NCBI chr15:29,206,328...29,213,398
Ensembl chr15:29,206,157...29,213,348
G
Rad54l
RAD54 like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAD54L mRNA
CTD
PMID:37748715
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Reep6
receptor accessory protein 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of REEP6 mRNA
CTD
PMID:37748715
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RFC2 mRNA
CTD
PMID:37748715
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rhbdd1
rhomboid domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RHBDD1 mRNA
CTD
PMID:37748715
NCBI chr 9:83,630,037...83,748,690
Ensembl chr 9:83,630,063...83,748,689
G
Rragc
Ras-related GTP binding C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RRAGC mRNA
CTD
PMID:37748715
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
G
Rspry1
ring finger and SPRY domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RSPRY1 mRNA
CTD
PMID:37748715
NCBI chr19:10,352,449...10,403,015
Ensembl chr19:10,353,821...10,401,102
G
Samm50
SAMM50 sorting and assembly machinery component
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SAMM50 mRNA
CTD
PMID:37748715
NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682
G
Sars1
seryl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SARS mRNA
CTD
PMID:37748715
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Sema6a
semaphorin 6A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SEMA6A mRNA
CTD
PMID:37748715
NCBI chr18:40,050,623...40,171,954
Ensembl chr18:40,050,624...40,171,954
G
Sesn1
sestrin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN1 mRNA
CTD
PMID:37748715
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sesn2
sestrin 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN2 mRNA
CTD
PMID:37748715
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sh3tc1
SH3 domain and tetratricopeptide repeats 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SH3TC1 mRNA
CTD
PMID:37748715
NCBI chr14:75,005,691...75,050,001
Ensembl chr14:75,016,875...75,049,995
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SHMT2 mRNA
CTD
PMID:37748715
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Ska2
spindle and kinetochore associated complex subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SKA2 mRNA
CTD
PMID:37748715
NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458
G
Slc1a4
solute carrier family 1 member 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC1A4 mRNA
CTD
PMID:37748715
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC1A5 mRNA
CTD
PMID:37748715
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc25a31
solute carrier family 25 member 31
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A31 mRNA
CTD
PMID:37748715
NCBI chr 2:123,695,387...123,711,275
Ensembl chr 2:123,695,408...123,710,795
G
Slc25a36
solute carrier family 25 member 36
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A36 mRNA
CTD
PMID:37748715
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
G
Slc25a4
solute carrier family 25 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A4 mRNA
CTD
PMID:37748715
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc26a2
solute carrier family 26 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC26A2 mRNA
CTD
PMID:37748715
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
G
Slc2a1
solute carrier family 2 member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC2A1 mRNA
CTD
PMID:37748715
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc35a4
solute carrier family 35, member A4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC35A4 mRNA
CTD
PMID:37748715
NCBI chr18:28,280,483...28,284,610
Ensembl chr18:28,279,750...28,284,725
G
Slc38a1
solute carrier family 38, member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A1 mRNA
CTD
PMID:37748715
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
G
Slc38a2
solute carrier family 38, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A2 mRNA
CTD
PMID:37748715
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc38a7
solute carrier family 38, member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A7 mRNA
CTD
PMID:37748715
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
G
Slc39a4
solute carrier family 39 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC39A4 mRNA
CTD
PMID:37748715
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc3a2
solute carrier family 3 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC3A2 mRNA
CTD
PMID:37748715
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc44a4
solute carrier family 44, member 4
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of SLC44A4 mRNA]
CTD
PMID:37748715
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC6A9 mRNA
CTD
PMID:37748715
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of SLC7A1 mRNA]
CTD
PMID:37748715
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a3
solute carrier family 7 member 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC7A3 mRNA
CTD
PMID:37748715
NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A5 mRNA
CTD
PMID:37748715
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc7a7
solute carrier family 7 member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A7 mRNA
CTD
PMID:37748715
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Smcr8
SMCR8-C9orf72 complex subunit
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMCR8 mRNA
CTD
PMID:37748715
NCBI chr10:45,457,962...45,465,101
Ensembl chr10:45,457,605...45,468,876
G
Smim22
small integral membrane protein 22
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMIM22 mRNA
CTD
PMID:37748715
NCBI chr10:10,572,146...10,574,339
G
Snord1c
small nucleolar RNA, C/D box 1C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNORD1C mRNA
CTD
PMID:37748715
NCBI chr10:101,905,797...101,905,872
Ensembl chr10:101,905,797...101,905,872
G
Snx4
sorting nexin 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNX4 mRNA
CTD
PMID:37748715
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Spag7
sperm associated antigen 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SPAG7 mRNA
CTD
PMID:37748715
NCBI chr10:55,377,249...55,383,404
Ensembl chr10:55,377,249...55,383,404
G
Sqle
squalene epoxidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SQLE mRNA
CTD
PMID:37748715
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srxn1
sulfiredoxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SRXN1 mRNA
CTD
PMID:37748715
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Stc2
stanniocalcin 2
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of STC2 mRNA]
CTD
PMID:37748715
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STIL mRNA
CTD
PMID:37748715
NCBI chr 5:128,520,837...128,573,732
Ensembl chr 5:128,520,953...128,573,730
G
Stx7
syntaxin 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STX7 mRNA
CTD
PMID:37748715
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Svil
supervillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SVIL mRNA
CTD
PMID:37748715
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Sycp1
synaptonemal complex protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SYCP1 mRNA
CTD
PMID:37748715
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
G
Tars1
threonyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TARS mRNA
CTD
PMID:37748715
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tas2r108
taste receptor, type 2, member 108
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAS2R108 mRNA
CTD
PMID:37748715
NCBI chr 4:69,287,667...69,288,581
Ensembl chr 4:69,287,667...69,288,581
G
Tat
tyrosine aminotransferase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAT mRNA
CTD
PMID:37748715
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbcc
tubulin folding cofactor C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TBCC mRNA
CTD
PMID:37748715
NCBI chr 9:14,098,855...14,100,043
Ensembl chr 9:14,098,868...14,100,042
G
Tdg
thymine-DNA glycosylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TDG mRNA
CTD
PMID:37748715
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
G
Tec
tec protein tyrosine kinase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TEC mRNA
CTD
PMID:37748715
NCBI chr14:35,352,551...35,461,585
Ensembl chr14:35,352,829...35,461,557
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TERF1 mRNA
CTD
PMID:37748715
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
G
Thap4
THAP domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of THAP4 mRNA
CTD
PMID:37748715
NCBI chr 9:94,242,581...94,282,312
Ensembl chr 9:94,242,581...94,282,306
G
Tmppe
transmembrane protein with metallophosphoesterase domain
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TMPPE mRNA
CTD
PMID:37748715
NCBI chr 8:114,085,497...114,093,388
Ensembl chr 8:114,084,831...114,094,286
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOP2A mRNA
CTD
PMID:37748715
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tor1aip1
torsin 1A interacting protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOR1AIP1 mRNA
CTD
PMID:37748715
NCBI chr13:68,196,681...68,226,121
Ensembl chr13:68,196,681...68,225,862
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRP53INP1 mRNA
CTD
PMID:37748715
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpcn2
two pore segment channel 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TPCN2 mRNA
CTD
PMID:37748715
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA]
CTD
PMID:37748715
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim32
tripartite motif-containing 32
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIM32 mRNA
CTD
PMID:37748715
NCBI chr 5:79,005,139...79,016,615
Ensembl chr 5:78,999,389...79,022,018
G
Trip12
thyroid hormone receptor interactor 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIP12 mRNA
CTD
PMID:37748715
NCBI chr 9:85,916,691...86,043,312
Ensembl chr 9:85,916,691...86,051,403
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRPM6 mRNA
CTD
PMID:37748715
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUBB5 mRNA
CTD
PMID:37748715
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tug1
taurine up-regulated 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUG1 mRNA
CTD
PMID:37748715
NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TXNIP mRNA
CTD
PMID:37748715
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ugdh
UDP-glucose 6-dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of UGDH mRNA
CTD
PMID:37748715
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Vangl1
VANGL planar cell polarity protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VANGL1 mRNA
CTD
PMID:37748715
NCBI chr 2:189,586,681...189,637,609
Ensembl chr 2:189,589,229...189,637,619
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VEGFA mRNA
CTD
PMID:37748715
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VTCN1 mRNA
CTD
PMID:37748715
NCBI chr 2:188,253,594...188,321,658
Ensembl chr 2:188,253,594...188,321,658
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YARS mRNA
CTD
PMID:37748715
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YIPF2 mRNA
CTD
PMID:37748715
NCBI chr 8:20,141,148...20,145,349
Ensembl chr 8:20,141,155...20,145,339
G
Ypel5
yippee-like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YPEL5 mRNA
CTD
PMID:37748715
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Zfp516
zinc finger protein 516
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZFP516 mRNA
CTD
PMID:37748715
NCBI chr18:76,286,453...76,386,526
Ensembl chr18:76,302,096...76,385,269
G
Zswim5
zinc finger, SWIM-type containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZSWIM5 mRNA
CTD
PMID:37748715
NCBI chr 5:130,346,733...130,463,791
Ensembl chr 5:130,343,034...130,463,784
G
Klrc1
killer cell lectin like receptor C1
decreases expression
ISO
sofosbuvir co-treated with ledipasvir decreased expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
G
Ncr1
natural cytotoxicity triggering receptor 1
affects expression
ISO
sofosbuvir co-treated with ledipasvir affects expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]]; Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]
CTD
PMID:18523137
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cysltr1
cysteinyl leukotriene receptor 1
multiple interactions
ISO
[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; [Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein; montelukast inhibits the reaction [[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; montelukast inhibits the reaction [[Uridine Diphosphate metabolite results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein]; Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein; zafirlukast inhibits the reaction [[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; zafirlukast inhibits the reaction [[Uridine Diphosphate metabolite results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein]
CTD
PMID:20083671
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Gpr17
G protein-coupled receptor 17
multiple interactions
ISO
cangrelor inhibits the reaction [Uridine Diphosphate results in increased activity of GPR17 protein]
CTD
PMID:18974869
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
H2ax
H2A.X variant histone
multiple interactions
ISO
Uridine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
CTD
PMID:32941855
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
increases abundance multiple interactions
ISO
IDH2 protein mutant form results in increased abundance of Uridine Diphosphate Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate]
CTD
PMID:27469509
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Il6
interleukin 6
multiple interactions increases expression
ISO
MRS 2211 inhibits the reaction [Uridine Diphosphate results in increased expression of IL6 protein]; P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:18523137 PMID:24849676
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO
Uridine Diphosphate results in increased phosphorylation of MAPK1 protein P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein]
CTD
PMID:15034929 PMID:18523137
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO
Uridine Diphosphate results in increased phosphorylation of MAPK3 protein P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK3 protein]
CTD
PMID:15034929 PMID:18523137
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
P2ry6
pyrimidinergic receptor P2Y6
multiple interactions affects response to substance
ISO
P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]]; P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein]; P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK3 protein] P2RY6 gene affects the susceptibility to Uridine Diphosphate
CTD
PMID:18523137
NCBI chr 1:155,295,110...155,330,610
Ensembl chr 1:155,295,111...155,330,808
G
Tp53bp1
tumor protein p53 binding protein 1
multiple interactions
ISO
Uridine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
CTD
PMID:32941855
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Gale
UDP-galactose-4-epimerase
affects binding
ISO
Uridine Diphosphate Galactose binds to GALE protein
CTD
PMID:25526675
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Gpr17
G protein-coupled receptor 17
increases activity
ISO
Uridine Diphosphate Galactose results in increased activity of GPR17 protein
CTD
PMID:18974869
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Uxs1
UDP-glucuronate decarboxylase 1
multiple interactions
ISO
[Uridine Diphosphate Galactose co-treated with NAD] binds to UXS1 protein
CTD
PMID:25526675
NCBI chr 9:653,740...731,121
Ensembl chr 9:653,659...756,334
G
Gale
UDP-galactose-4-epimerase
affects binding
ISO
Uridine Diphosphate Glucose binds to GALE protein
CTD
PMID:25526675
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Gpr17
G protein-coupled receptor 17
increases activity
ISO
Uridine Diphosphate Glucose results in increased activity of GPR17 protein
CTD
PMID:18974869
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Uxs1
UDP-glucuronate decarboxylase 1
multiple interactions
ISO
[Uridine Diphosphate Glucose co-treated with NAD] binds to UXS1 protein
CTD
PMID:25526675
NCBI chr 9:653,740...731,121
Ensembl chr 9:653,659...756,334
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[NADP co-treated with Uridine Diphosphate Glucuronic Acid co-treated with Phosphoadenosine Phosphosulfate] promotes the reaction [[Enzymes and Coenzymes results in increased metabolism of diosbulbin B] inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]; [NADP co-treated with Uridine Diphosphate Glucuronic Acid co-treated with Phosphoadenosine Phosphosulfate] promotes the reaction [[Enzymes and Coenzymes results in increased metabolism of saikogenin A analog] inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]; [NADP co-treated with Uridine Diphosphate Glucuronic Acid co-treated with Phosphoadenosine Phosphosulfate] promotes the reaction [[Enzymes and Coenzymes results in increased metabolism of saikogenin A] inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]
CTD
PMID:35101544
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
B3gat3
beta-1,3-glucuronyltransferase 3
affects binding multiple interactions
ISO
B3GAT3 protein binds to Uridine Diphosphate Glucuronic Acid Uridine Diphosphate Glucuronic Acid inhibits the reaction [Diacetyl results in decreased activity of B3GAT3 protein]
CTD
PMID:11986319
NCBI chr 1:205,817,374...205,823,928
Ensembl chr 1:205,817,378...205,837,807
G
Gale
UDP-galactose-4-epimerase
affects binding
ISO
Uridine Diphosphate Glucuronic Acid binds to GALE protein
CTD
PMID:25526675
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression
ISO
Uridine Diphosphate Glucuronic Acid results in increased expression of PPARGC1A mRNA
CTD
PMID:23056435
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
ISO
[Uridine Diphosphate Glucuronic Acid co-treated with UGT1A1 protein] results in increased glucuronidation of Labetalol
CTD
PMID:18098064
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
multiple interactions
ISO
[Uridine Diphosphate Glucuronic Acid co-treated with UGT1A3 protein] results in increased metabolism of Lithocholic Acid
CTD
PMID:36473578
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol; [Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased metabolism of hyodeoxycholic acid; Fluconazole inhibits the reaction [[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol]
CTD
PMID:18098064 PMID:36473578
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Uxs1
UDP-glucuronate decarboxylase 1
multiple interactions
ISO
[Uridine Diphosphate Glucuronic Acid co-treated with NAD] binds to UXS1 protein
CTD
PMID:25526675
NCBI chr 9:653,740...731,121
Ensembl chr 9:653,659...756,334
G
Gale
UDP-galactose-4-epimerase
affects binding
ISO
Uridine Diphosphate Galactose binds to GALE protein
CTD
PMID:25526675
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Gpr17
G protein-coupled receptor 17
increases activity
ISO
Uridine Diphosphate Galactose results in increased activity of GPR17 protein
CTD
PMID:18974869
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Uxs1
UDP-glucuronate decarboxylase 1
multiple interactions
ISO
[Uridine Diphosphate Galactose co-treated with NAD] binds to UXS1 protein
CTD
PMID:25526675
NCBI chr 9:653,740...731,121
Ensembl chr 9:653,659...756,334
G
Gale
UDP-galactose-4-epimerase
affects binding
ISO
Uridine Diphosphate Glucose binds to GALE protein
CTD
PMID:25526675
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Gpr17
G protein-coupled receptor 17
increases activity
ISO
Uridine Diphosphate Glucose results in increased activity of GPR17 protein
CTD
PMID:18974869
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Uxs1
UDP-glucuronate decarboxylase 1
multiple interactions
ISO
[Uridine Diphosphate Glucose co-treated with NAD] binds to UXS1 protein
CTD
PMID:25526675
NCBI chr 9:653,740...731,121
Ensembl chr 9:653,659...756,334
G
Gale
UDP-galactose-4-epimerase
affects binding
ISO
Uridine Diphosphate N-Acetylgalactosamine binds to GALE protein
CTD
PMID:25526675
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
multiple interactions increases abundance
ISO
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate N-Acetylglucosamine]
CTD
PMID:27469509
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Adora1
adenosine A1 receptor
increases activity
EXP
Uridine results in increased activity of ADORA1 protein
CTD
PMID:18313046
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
Uridine inhibits the reaction [celastrol results in increased expression of BAX protein]
CTD
PMID:27374097
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Casp3
caspase 3
multiple interactions
ISO
Uridine inhibits the reaction [celastrol results in increased cleavage of CASP3 protein]
CTD
PMID:27374097
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
Uridine inhibits the reaction [celastrol results in increased cleavage of CASP9 protein]
CTD
PMID:27374097
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Col2a1
collagen type II alpha 1 chain
multiple interactions
EXP
[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uridine; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uridine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uridine]; huang-lien-chieh-tu-tang inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uridine]
CTD
PMID:24709313
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
multiple interactions
ISO
[Pyruvic Acid co-treated with Uridine co-treated with Ethidium] inhibits the reaction [Rotenone inhibits the reaction [arsenite results in increased expression of ERO1A protein]]
CTD
PMID:37659621
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Faslg
Fas ligand
increases expression
ISO
Uridine results in increased expression of FASLG protein
CTD
PMID:16419169
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gypa
glycophorin A
multiple interactions
ISO
Uridine inhibits the reaction [teriflunomide results in increased expression of GYPA protein]
CTD
PMID:12181422
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
multiple interactions increases abundance
ISO
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine]
CTD
PMID:27469509
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
multiple interactions
ISO
Uridine inhibits the reaction [Zalcitabine results in decreased expression of COX1 protein]; Uridine inhibits the reaction [Zidovudine results in decreased expression of COX1 protein]
CTD
PMID:17187420 PMID:18163507 PMID:20032772
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
Uridine inhibits the reaction [Adenosine results in decreased expression of MYC protein]
CTD
PMID:9808420
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Slc28a1
solute carrier family 28 member 1
multiple interactions increases uptake increases export increases transport
ISO EXP
Adenosine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Cytarabine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine]; Cytidine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Gemcitabine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine]; Lamivudine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine]; Sodium affects the reaction [SLC28A1 protein results in increased uptake of Uridine]; Thymidine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Zidovudine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine] SLC28A1 protein results in increased export of Uridine Cytarabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Gemcitabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Idoxuridine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Zalcitabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Zalcitabine promotes the reaction [SLC28A1 protein results in increased export of Uridine]; Zidovudine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Zidovudine promotes the reaction [SLC28A1 protein results in increased export of Uridine]
CTD
PMID:8700147 PMID:8713072 PMID:9124315 PMID:10772724
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
G
Slc28a2
solute carrier family 28 member 2
increases transport
ISO
SLC28A2 protein results in increased transport of Uridine
CTD
PMID:10087507
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc29a1
solute carrier family 29 member 1
multiple interactions increases uptake
ISO EXP
4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]; 4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; [SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine; Dilazep inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]; Lidoflazine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine] 4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Adenosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Cytidine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Guanosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Inosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Thymidine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Uridine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine] 2'-deoxyadenosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; 4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Cytidine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Dilazep inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Guanosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Inosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]; Thymidine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]
CTD
PMID:9353301 PMID:9396714 PMID:10366666 PMID:11085929 PMID:18381442
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc29a2
solute carrier family 29 member 2
multiple interactions increases uptake
ISO EXP
4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]; [SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine; Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]] SLC29A2 protein results in increased uptake of Uridine 2'-deoxyadenosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]; Adenine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]; Cytidine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]; Dipyridamole inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]; Guanosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]; Inosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]; Thymidine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]
CTD
PMID:9353301 PMID:9396714 PMID:10366666 PMID:11085929
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Tp53
tumor protein p53
multiple interactions
ISO
Uridine inhibits the reaction [celastrol results in increased expression of TP53 protein]
CTD
PMID:27374097
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Upp1
uridine phosphorylase 1
affects abundance multiple interactions increases metabolic processing
ISO
UPP1 protein affects the abundance of Uridine [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil; [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital
CTD
PMID:15772079
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Bsg
basigin (Ok blood group)
decreases expression
ISO
Uridine Monophosphate results in decreased expression of BSG protein
CTD
PMID:36574092
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
G
Ahr
aryl hydrocarbon receptor
multiple interactions
EXP
Uridine Triphosphate affects the folding of [Tetrachlorodibenzodioxin binds to AHR protein]
CTD
PMID:1848756
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Calca
calcitonin-related polypeptide alpha
multiple interactions
EXP
Uridine Triphosphate promotes the reaction [Protons results in increased secretion of CALCA protein]
CTD
PMID:12044622
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Egfr
epidermal growth factor receptor
increases phosphorylation
EXP
Uridine Triphosphate results in increased phosphorylation of EGFR protein
CTD
PMID:14676212
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Gnaq
G protein subunit alpha q
multiple interactions
EXP
Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]
CTD
PMID:14676212
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
G
H2ax
H2A.X variant histone
multiple interactions
ISO
Uridine Triphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
CTD
PMID:32941855
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hcar2
hydroxycarboxylic acid receptor 2
multiple interactions
ISO
[Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids]; [Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids]
CTD
PMID:16674924
NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504
G
Il6
interleukin 6
multiple interactions increases expression
ISO
NF157 compound inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein]; Suramin inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein] MRS 2211 inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein]
CTD
PMID:24793913 PMID:24849676
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids]; [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids; Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein RTKI cpd inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] Uridine Triphosphate results in increased phosphorylation of MAPK1 protein
CTD
PMID:14676212 PMID:15034929 PMID:16674924
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids]; [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids; Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein RTKI cpd inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] Uridine Triphosphate results in increased phosphorylation of MAPK3 protein
CTD
PMID:14676212 PMID:15034929 PMID:16674924
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Myl2
myosin light chain 2
multiple interactions
EXP
Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein]
CTD
PMID:14676212
NCBI chr12:34,454,223...34,468,554
Ensembl chr12:34,454,218...34,468,983
G
Myocd
myocardin
multiple interactions
EXP
Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein]; Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of NPPA protein]
CTD
PMID:14676212
NCBI chr10:49,833,219...49,928,806
Ensembl chr10:49,836,641...49,927,627
G
Nppa
natriuretic peptide A
multiple interactions increases expression
EXP
Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of NPPA protein]; Uridine Triphosphate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] Uridine Triphosphate results in increased expression of NPPA mRNA
CTD
PMID:14676212
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
P2rx1
purinergic receptor P2X 1
affects binding
EXP
UTP binds to P2rx1 protein
RGD
PMID:12237343
RGD:727431
NCBI chr10:57,618,586...57,633,648
Ensembl chr10:57,618,586...57,633,623
G
P2ry2
purinergic receptor P2Y2
multiple interactions
EXP ISO
Uridine Triphosphate binds to and results in increased activity of P2RY2 protein Endocannabinoids inhibits the reaction [Uridine Triphosphate binds to and results in increased activity of P2RY2 protein]; Uridine Triphosphate binds to and results in increased activity of P2RY2 protein
CTD
PMID:15654852 PMID:30102254
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
G
P2ry4
pyrimidinergic receptor P2Y4
multiple interactions
EXP
Uridine Triphosphate binds to and results in increased activity of P2RY4 protein
CTD
PMID:15654852
NCBI chr X:65,681,680...65,717,404
Ensembl chr X:65,683,232...65,721,748
G
Panx1
Pannexin 1
decreases activity
ISO
Uridine Triphosphate results in decreased activity of PANX1 protein
CTD
PMID:19023039
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
G
Sftpb
surfactant protein B
increases secretion
ISO
Uridine Triphosphate results in increased secretion of SFTPB protein
CTD
PMID:14565945
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
increases secretion
ISO
Uridine Triphosphate results in increased secretion of SFTPC protein
CTD
PMID:14565945
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Tp53bp1
tumor protein p53 binding protein 1
multiple interactions
ISO
Uridine Triphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
CTD
PMID:32941855
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
multiple interactions increases activity
ISO
ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Uridine Triphosphate results in increased activity of TRPC3 protein]
CTD
PMID:19289841
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
G
Trpc5
transient receptor potential cation channel, subfamily C, member 5
increases activity
ISO
Uridine Triphosphate results in increased activity of TRPC5 protein
CTD
PMID:19289841
NCBI chr X:107,946,163...108,230,991
Ensembl chr X:107,939,131...108,230,991
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
increases activity
ISO
Uridine Triphosphate results in increased activity of TRPC6 protein
CTD
PMID:19289841
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpc7
transient receptor potential cation channel, subfamily C, member 7
increases activity
ISO
Uridine Triphosphate results in increased activity of TRPC7 protein
CTD
PMID:19289841
NCBI chr17:7,708,911...7,833,435
Ensembl chr17:7,709,583...7,833,435
G
Akt3
AKT serine/threonine kinase 3
multiple interactions
EXP
pyrimidin-2-one beta-ribofuranoside affects the reaction [Folic Acid affects the methylation of AKT3 gene]
CTD
PMID:24629913
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
G
Ankrd6
ankyrin repeat domain 6
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of ANKRD6 mRNA
CTD
PMID:19194470
NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090
G
Apaf1
apoptotic peptidase activating factor 1
affects expression
ISO
pyrimidin-2-one beta-ribofuranoside affects the expression of APAF1 mRNA
CTD
PMID:17133271
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apobec3
apolipoprotein B mRNA editing enzyme catalytic subunit 3
multiple interactions
ISO
[pyrimidin-2-one beta-ribofuranoside results in decreased activity of APOBEC3B protein] which results in increased susceptibility to Decitabine; pyrimidin-2-one beta-ribofuranoside inhibits the reaction [APOBEC3B protein results in decreased amination of Decitabine]
CTD
PMID:18398609
NCBI chr 7:111,433,789...111,453,032
Ensembl chr 7:111,433,764...111,452,922
G
App
amyloid beta precursor protein
multiple interactions
ISO
pyrimidin-2-one beta-ribofuranoside inhibits the reaction [Folic Acid results in decreased expression of APP protein]
CTD
PMID:26492244
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bax
BCL2 associated X, apoptosis regulator
affects cleavage
ISO
pyrimidin-2-one beta-ribofuranoside affects the cleavage of BAX protein
CTD
PMID:19459041
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
affects cleavage decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside affects the cleavage of BCL2 protein pyrimidin-2-one beta-ribofuranoside results in decreased expression of BCL2 protein
CTD
PMID:19459041 PMID:23320119
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases cleavage
ISO
pyrimidin-2-one beta-ribofuranoside results in increased cleavage of CASP3 protein
CTD
PMID:19459041
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
pyrimidin-2-one beta-ribofuranoside results in increased activity of CASP8 protein
CTD
PMID:23320119
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity
ISO
pyrimidin-2-one beta-ribofuranoside results in increased activity of CASP9 protein
CTD
PMID:23320119
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccnd1
cyclin D1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of CCND1 protein
CTD
PMID:19459041
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of CDK2 protein
CTD
PMID:23320119
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of CDKN1A protein pyrimidin-2-one beta-ribofuranoside results in increased expression of CDKN1A protein
CTD
PMID:19459041 PMID:23320119
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Creb1
cAMP responsive element binding protein 1
increases phosphorylation
ISO
pyrimidin-2-one beta-ribofuranoside results in increased phosphorylation of CREB1 protein
CTD
PMID:18830594
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Csgalnact2
chondroitin sulfate N-acetylgalactosaminyltransferase 2
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of CSGALNACT2 mRNA
CTD
PMID:19194470
NCBI chr 4:151,271,774...151,308,856
Ensembl chr 4:151,277,645...151,308,839
G
Cux1
cut-like homeobox 1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of CUX1 mRNA
CTD
PMID:19194470
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
G
Derl1
derlin 1
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of DERL1 mRNA
CTD
PMID:19194470
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases response to substance decreases expression
ISO
EIF2AK2 protein results in decreased susceptibility to pyrimidin-2-one beta-ribofuranoside pyrimidin-2-one beta-ribofuranoside results in decreased expression of EIF2AK2 protein modified form
CTD
PMID:23320119
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Esr1
estrogen receptor 1
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of ESR1 mRNA
CTD
PMID:19459041
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
H2ax
H2A.X variant histone
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of H2AX protein
CTD
PMID:17991895
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of HSP90AA1 protein
CTD
PMID:18830594
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Igfbp3
insulin-like growth factor binding protein 3
affects expression
ISO
pyrimidin-2-one beta-ribofuranoside affects the expression of IGFBP3 mRNA
CTD
PMID:16505122
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
pyrimidin-2-one beta-ribofuranoside affects the expression of JUNB mRNA
CTD
PMID:16505122
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Larp7
La ribonucleoprotein 7, transcriptional regulator
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of LARP7 mRNA
CTD
PMID:19194470
NCBI chr 2:215,997,641...216,012,833
Ensembl chr 2:215,997,649...216,012,865
G
Map1a
microtubule-associated protein 1A
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of MAP1A mRNA
CTD
PMID:19194470
NCBI chr 3:108,263,217...108,283,936
Ensembl chr 3:108,263,151...108,282,899
G
Mapk1
mitogen activated protein kinase 1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of MAPK1 protein modified form
CTD
PMID:23320119
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of MAPK3 protein modified form
CTD
PMID:23320119
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of MAPK8IP3 mRNA
CTD
PMID:19194470
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Mbd2
methyl-CpG binding domain protein 2
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of MBD2 protein
CTD
PMID:19459041
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbd3
methyl-CpG binding domain protein 3
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of MBD3 protein
CTD
PMID:19459041
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Mecp2
methyl CpG binding protein 2
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of MECP2 protein
CTD
PMID:19459041
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Mtrf1l
mitochondrial translation release factor 1 like
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of MTRF1L mRNA
CTD
PMID:19194470
NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836
G
Nfatc2ip
nuclear factor of activated T-cells 2 interacting protein
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of NFATC2IP mRNA
CTD
PMID:19194470
NCBI chr 1:180,954,834...180,971,847
Ensembl chr 1:180,955,043...180,971,747
G
Nfic
nuclear factor I/C
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of NFIC mRNA
CTD
PMID:19194470
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
pyrimidin-2-one beta-ribofuranoside results in increased cleavage of PARP1 protein
CTD
PMID:19459041
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Phldb1
pleckstrin homology-like domain, family B, member 1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of PHLDB1 mRNA
CTD
PMID:19194470
NCBI chr 8:45,003,543...45,051,541
Ensembl chr 8:45,003,538...45,051,522
G
Pml
PML nuclear body scaffold
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of PML mRNA
CTD
PMID:19194470
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Rabgap1l
RAB GTPase activating protein 1-like
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of RABGAP1L mRNA
CTD
PMID:19194470
NCBI chr13:72,464,114...73,059,845
Ensembl chr13:72,468,110...73,059,984
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of RB1 protein modified form
CTD
PMID:23320119
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbm34
RNA binding motif protein 34
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of RBM34 mRNA
CTD
PMID:19194470
NCBI chr19:54,936,516...54,956,810
Ensembl chr19:54,936,531...54,956,715
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of RRM2B mRNA
CTD
PMID:19010910
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
G
RT1-Bb
RT1 class II, locus Bb
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of HLA-DQB1 mRNA
CTD
PMID:19194470
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Sla
src-like adaptor
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of SLA mRNA
CTD
PMID:19194470
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Snip1
Smad nuclear interacting protein 1
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of SNIP1 mRNA
CTD
PMID:19194470
NCBI chr 5:137,328,371...137,335,846
Ensembl chr 5:137,328,371...137,335,845
G
Sod2
superoxide dismutase 2
multiple interactions decreases methylation
ISO
[pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 gene] which results in increased expression of SOD2 protein; [pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 promoter] which results in increased expression of SOD2 mRNA; [pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 promoter] which results in increased expression of SOD2 protein
CTD
PMID:15908783 PMID:17895890
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of ST3GAL6 mRNA
CTD
PMID:19194470
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
G
Tfe3
transcription factor binding to IGHM enhancer 3
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of TFE3 mRNA
CTD
PMID:19194470
NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571
G
Tp53
tumor protein p53
increases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in increased expression of TP53 protein
CTD
PMID:23320119
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Wdr47
WD repeat domain 47
decreases expression
ISO
pyrimidin-2-one beta-ribofuranoside results in decreased expression of WDR47 mRNA
CTD
PMID:19194470
NCBI chr 2:196,226,757...196,287,739
Ensembl chr 2:196,205,238...196,287,739
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all